Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U2 small nuclear 72, pseudogene (RNU2-72P) is classified as a human pseudogene located on chromosome 10[6]. It is related to U2 small nuclear RNA (snRNA) genes, which are components of the spliceosome involved in the splicing of precursor messenger RNA (pre-mRNA), but this specific locus is annotated as a pseudogene, meaning it does not encode a functional RNA or protein and is generally not considered biologically active or therapeutically relevant[6][1]. There is no evidence linking RNU2-72P to disease, biological function, or drug interactions, and it is not considered a therapeutic target[6][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 72, pseudogene (RNU2-72P).